Related Experiment Video
Updated: Jul 6, 2026
06:31
Erosion Identification in Metacarpophalangeal Joints in Rheumatoid Arthritis using High-Resolution Peripheral Quantitative Computed Tomography
Published on: October 6, 2023
Rheumatologists, take heart! We may be doing something right.
Arthritis Research & Therapy
|March 18, 2008
Summary
Effective antirheumatic therapies, including disease-modifying antirheumatic drugs (DMARDs) and biologics, appear to lower cardiovascular disease risk in rheumatoid arthritis patients. This finding suggests treatment impacts long-term heart health in those with RA.
Area of Science:
- Rheumatology
- Cardiovascular Medicine
- Clinical Epidemiology
Background:
- Rheumatoid arthritis (RA) is associated with an increased risk of cardiovascular disease (CVD).
- Traditional cardiovascular risk factors are prevalent in RA patients.
- Extraarticular disease manifestations in RA correlate with higher CVD risk.
Discussion:
- This study investigates the impact of antirheumatic therapies on CVD risk in RA.
- Data from the QUEST-RA group, a large international collaboration, were analyzed cross-sectionally.
- Methodological limitations warrant consideration and suggest the need for further research.
Key Insights:
- Effective treatment with disease-modifying antirheumatic drugs (DMARDs), glucocorticoids, or anti-TNF biologics is linked to reduced CVD risk in RA patients.
- Traditional risk factors remain significant predictors of cardiovascular events in this cohort.
- The association between extraarticular disease and increased CVD risk is confirmed.
Outlook:
- Confirmatory studies are recommended to validate these findings.
- Further research should explore the precise mechanisms by which antirheumatic therapies mitigate CVD risk.
- These results may inform clinical practice guidelines for managing cardiovascular health in RA.
Related Concept Videos
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
01:20Rheumatic Heart Disease IV: Nursing Management
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
01:17Pericarditis III: Medical Management
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...